张佳, 赵婷, 敦洁宁, 孙明贤, 黄荣荣, 向柏, 白靖, 曹德英. 门控型药物递送系统研究进展J. 药学学报, 2019,54(6): 1017-1025. doi: 10.16438/j.0513-4870.2019-0134
引用本文: 张佳, 赵婷, 敦洁宁, 孙明贤, 黄荣荣, 向柏, 白靖, 曹德英. 门控型药物递送系统研究进展J. 药学学报, 2019,54(6): 1017-1025. doi: 10.16438/j.0513-4870.2019-0134
ZHANG Jia, ZHAO Ting, DUN Jie-ning, SUN Ming-xian, HUANG Rong-rong, XIANG Bai, BAI Jing, CAO De-ying. Research progress of drug delivery system with “gatekeeper”J. Acta Pharmaceutica Sinica, 2019,54(6): 1017-1025. doi: 10.16438/j.0513-4870.2019-0134
Citation: ZHANG Jia, ZHAO Ting, DUN Jie-ning, SUN Ming-xian, HUANG Rong-rong, XIANG Bai, BAI Jing, CAO De-ying. Research progress of drug delivery system with “gatekeeper”J. Acta Pharmaceutica Sinica, 2019,54(6): 1017-1025. doi: 10.16438/j.0513-4870.2019-0134

门控型药物递送系统研究进展

Research progress of drug delivery system with “gatekeeper”

  • 摘要: 门控型药物递送系统,旨在通过门控基团使药物在正常生理条件下处于稳定包载状态。而在肿瘤等病变微环境或外源性因素刺激下,门控基团脱落或改变实现药物的响应性释放。本文主要针对刺激响应性连接臂和刺激响应性基团两个方面的应用,综述了近10年门控型药物递送系统的研究进展。

     

    Abstract: The drug delivery system with "gatekeeper" is designed to achieve a stable entrapment state of the payload under normal physiological conditions through the gatekeepers. With tumor microenvironment or stimulation of exogenous factors, the gatekeeper is detached or altered to promote the responsive release of the drug. In this paper, we focus on applications of stimuli-responsive linkages and stimuli-responsive groups, and review research progresses of drug delivery system with "gatekeeper" developed over the past 10 years.

     

/

返回文章
返回